Companies researching Xtandi (Enzalutamide)
Enzalutamide, marketed under the brand name Xtandi, is a nonsteroidal antiandrogen drug used to treat prostate cancer.
8
companies
List of companies that research Xtandi (Enzalutamide)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
Japan | Pharmaceutical Manufacturing | 12k | Xtandi (Enzalutamide) | ||
United Kingdom | Research Services | 1.6k | $35M | Xtandi (Enzalutamide) | |
Spain | Pharmaceutical Manufacturing | 1.4k | Xtandi (Enzalutamide) | ||
United States | IT Services and IT Consulting | 55 | Xtandi (Enzalutamide) |
Showing top companies out of 8 that research Xtandi (Enzalutamide). Get the full list on TheirStack.
Frequently asked questions



